Upregulation of transcription factors in the AP1 and ETs families coincide with the development of ER+ breast cancer and are able to promote increased transcription of MDM2, even in the absence of p53, from the normally p53-dependent MDM2 promoter (37). Here, TP53 is linked to breast cancer.